Ionis Pharmaceuticals | IONS - Gross Profit On Sales


Ionis Pharmaceuticals reported $265M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 19.43M 1.34M Mar/2026
Alnylam Pharmaceuticals USD 992.69M 167.68M Jun/2026
Arrowhead Research USD 73.74M 190.3M Mar/2026
Astellas Pharma JPY 482.54B 38.28B Jun/2026
BioCryst Pharmaceuticals USD 214.41M 61.36M Jun/2026
BioMarin Pharmaceutical USD 713.42M 142.21M Jun/2026
Celltrion KRW 39.29B 7.7B Mar/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Exelixis USD 590.86M 18.68M Mar/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Moderna USD -566M 792M Mar/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Neurocrine Biosciences USD 800.7M 12.8M Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Omeros USD -33.16M 18.52M Jun/2024
OPKO Health USD 45.76M 755K Mar/2026
Organigram Holdings CAD 16.41M 6.91M Mar/2026
Pfizer USD -248M 11.29B Jun/2026
Pharma Mar EUR 44.87M 5.63M Jun/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Qiagen NV USD 309.6M 15.67M Mar/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sarepta Therapeutics USD 251.15M 370.2M Jun/2026
Sartorius EUR 433.1M 18.6M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 57.47M 10.16M Jun/2025
Ultragenyx Pharmaceutical USD 180M 74M Jun/2026
Vertex Pharmaceuticals USD 2.84B 242.4M Jun/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026